U.S. markets closed
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow 30

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     
  • Crude Oil

    61.66
    -1.87 (-2.94%)
     
  • Gold

    1,733.00
    -42.40 (-2.39%)
     
  • Silver

    26.70
    -0.98 (-3.56%)
     
  • EUR/USD

    1.2088
    -0.0099 (-0.81%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • GBP/USD

    1.3922
    -0.0091 (-0.65%)
     
  • USD/JPY

    106.5500
    +0.3200 (+0.30%)
     
  • BTC-USD

    44,750.59
    -2,746.14 (-5.78%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

Sabra Health Care REIT, Inc. Announces Third Quarter 2020 Earnings Release Date and Conference Call

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today that it will issue its 2020 third quarter earnings release on November 5, 2020.

A conference call with a simultaneous webcast to discuss the 2020 third quarter results will be held on Friday, November 6, at 9:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 6399235.

The webcast URL is https://edge.media-server.com/mmc/p/3w8kxwog. A digital replay of the call will be available on our website at www.sabrahealth.com.

About Sabra

Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201022005206/en/

Contacts

Investor & Media Inquiries:
1-888-393-8248
investorinquiries@sabrahealth.com